Description
Crave Control supports the synthesis of the brain reward
neurotransmitters (like serotonin and catecholamines) and
through its effect on the natural opioids will, by virtue of
inhibiting GABA, cause a significant release of dopamine
at the nucleus accumbens. This constant release of
possibly therapeutic amounts of dopamine, leads to
proliferation of D2 receptors, thereby promoting appetite
suppression and reducing overall craving in general.